info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Prostate cancer Companies

Prostate cancer diagnosis and therapy companies focus on developing and providing innovative technologies, diagnostics, and treatment options for the detection and management of prostate cancer. Prostate cancer is one of the most prevalent forms of cancer in men, and these companies play a crucial role in improving early detection and treatment outcomes.

Prostate Cancer Diagnosis and Therapy Key Companies*Disclaimer: List of key companies in no particular orderLatest Prostate cancer diagnosis and therapy Companies Update



  • Oct 2023: According to Astellas Pharma Inc., the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion on October 12 regarding the use of VEOZA™ (fezolinetant) 45 mg every day for the treatment of mild to severe vasomotor symptoms (VMS) related to menopause.4. Hot flashes or night sweats, commonly referred to as VMS, are typical menopausal symptoms.5,6 Fezolinetant will be a first-in-class, nonhormonal therapeutic option to lessen moderate to severe vasomotor symptoms (VMS) associated with menopause if authorized by the European Commission (EC). To lessen the incidence and severity of hot flashes and night sweats, fezolinetant prevents neurokinin B (NKB) from binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron. This helps to restore equilibrium in the hypothalamus, the brain's temperature control center.




  • Aug 2023: According to statements from investor Artisan Partners, Bayer must undergo significant changes, including the "de-merging" of two of its three core business units. According to the report, this request for modification is one more in a long line of requests for change from different investors. Bluebell Capital Partners, an activist shareholder, had also called for the company's dissolution earlier this year. Moreover, well-known investors like the mutual fund group Deka had harsh criticism for the company's past management. Some investors have proposed that dividing the healthcare and agriculture sectors into two distinct companies would be an easy fix. According to Artisan, the drug-to-pesticide company should look for new owners for its pharmaceutical and over-the-counter businesses.


List of Prostate cancer diagnosis and therapy Key companies in the market

  • Abbvie Inc.

  • AstraZeneca

  • Bayer AG

  • Sanofi

  • IpsenPharma

  • AstellasPharma Inc.

  • Johnson & Johnson Services Inc.

  • Tolmar Pharmaceuticals Inc.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.